Co-Diagnostics, Inc. Common Stock (CODX)

Co-Diagnostics, Inc. Common Stock (CODX) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.6M; returns 1 day -4.3%, 1 week -16.6%, 1 year -94.5%.

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests. Their core technology is the patented Co-Primers platform, designed to reduce non-specific amplification in PCR testing. The company is currently focused on the Co-Dx PCR platform for point-of-care (PoC) and at-home testing.

Groups CODX belongs to

• Healthcare
• Recent Reverse Splits
• Health Diagnostics and Imaging
• Medical Devices
• Life Sciences Tools & Services
• Infectious Diseases
• Healthcare Technology
• Biotechnology

CODX financial model: income statement, cash flow and balance sheet